For those of us that have followed and believed the CXS story, this is the last chance at buying at these low levels. Sure theres a risk that the data wont prompt Cephalon to exercise, but this would really be a turnaround on all of the pointers that have been seen over the last 18 months. Ive piled up on these (again!)in anticipation of the iminent announcement, hopefully the long wait has been worthwhile
promising biotech, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)